Cardinal Health, Inc. vs Abbvie Inc.
CAH vs ABBV — side-by-side comparison from reported financials. CAH leads 8, ABBV leads 4 of 12 comparable metrics.
Cardinal Health, Inc.
CAH · Healthcare
$237.57-0.58%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | CAH | ABBV |
|---|---|---|
| Price | $237.57 | $276.43 |
| Market cap | $55.0B | $488B |
| Revenue (TTM) | $254B | $64.4B |
| Revenue growth | +7.4% | +1.8% |
| Net margin | 0.7% | 9.8% |
| Free cash flow | $4.53B | $18.2B |
| Net cash (debt) | ($5.14B) | ($56.2B) |
| 1-year price return | +51.1% | +19.8% |
| P/E | 32.1 | 77.4 |
| P/E vs own history (cheap-side %) | 26% | 23% |
| Dividend yield | 0.89% | 2.45% |
| Return on equity | 37% | 96% |
| Altman Z-score | 5.09 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 63,900 | 57,000 |
Full résumé-style profiles: CAH CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.